Avantium N.V. (AMS:AVTX)
13.77
-0.36 (-2.53%)
Aug 12, 2025, 5:35 PM CET
Elevation Oncology Market Cap
Avantium has a market cap or net worth of €121.17 million as of August 12, 2025. Its market cap has decreased by -38.18% in one year.
Market Cap
121.17M
Enterprise Value
240.79M
Revenue
21.04M
Ranking
n/a
PE Ratio
n/a
Stock Price
$13.77
Market Cap Chart
Since March 15, 2017, Avantium's market cap has decreased from 150.37M to 121.17M, a decrease of -19.42%. That is a compound annual growth rate of -2.53%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 11, 2025 | 124.32M | -20.60% |
Dec 31, 2024 | 156.59M | 2.76% |
Dec 29, 2023 | 152.39M | -1.98% |
Dec 30, 2022 | 155.47M | -7.88% |
Dec 31, 2021 | 168.77M | 1.98% |
Dec 31, 2020 | 165.50M | 103.78% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Mar 15, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
ArcelorMittal | 21.62B |
DSM-Firmenich AG | 21.50B |
Akzo Nobel | 9.48B |
IMCD N.V. | 5.58B |
Aperam | 1.90B |
OCI N.V. | 1.59B |
Corbion | 951.83M |
AMG Critical Materials | 789.30M |